Jort Vijverberg, MD, PhD, discusses the role of biomarkers in providing a diagnosis of AD. He discusses considerations regarding procedures for differentiating AD from other conditions before moving on to describe the available fluid and neuroimaging biomarkers for AD. He finishes by discussing the expectations of patients and key considerations for HCPs when delivering a diagnosis of AD.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.